All posts by BTS Research
Government officials say they are now certain they know who launched the NotPetya cyberwar that slammed operations at Merck last year.
Shares of Pacira plunged more than 15 percent this morning after the company revealed the FDA panel’s decision.
Makena was approved by the FDA in February 2011 and remains the first and only FDA-approved treatment option currently available for pregnant women who have had a prior spontaneous preterm birth.
The FDA released five guidances on treatments for a variety of neurological disorders including Duchenne muscular dystrophy and Alzheimer’s disease, offering suggestions for trial designs and methods of measuring effectiveness.
Source: Drug Industry Daily